Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000813899 | SCV000954281 | pathogenic | Immunodeficiency, common variable, 2 | 2024-01-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys193*) in the TNFRSF13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TNFRSF13B are known to be pathogenic (PMID: 16007087, 27123465). This variant is present in population databases (rs72553885, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with TNFRSF13B-related conditions (PMID: 18981294, 27123465, 30993493). ClinVar contains an entry for this variant (Variation ID: 657318). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV000996499 | SCV001151227 | pathogenic | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | TNFRSF13B: PVS1, PM2, PS4:Supporting |
Biochemical Molecular Genetic Laboratory, |
RCV000813899 | SCV001469225 | pathogenic | Immunodeficiency, common variable, 2 | 2020-06-07 | no assertion criteria provided | clinical testing |